Gray HJ - Search Results

1

OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.

Hardesty MM, Krivak TC, Wright GS, Hamilton E, Fleming EL, Belotte J, Keeton EK, Wang P, Gupta D, Clements A, Gray HJ, Konecny GE, Moore RG, Richardson DL. Hardesty MM, et al. Among authors: gray hj. Gynecol Oncol. 2022 Aug;166(2):219-229. doi: 10.1016/j.ygyno.2022.05.020. Epub 2022 Jun 9. Gynecol Oncol. 2022. PMID: 35690498 Free article. Clinical Trial.

2

Glassy cell carcinoma of the cervix revisited.

Gray HJ, Garcia R, Tamimi HK, Koh WJ, Goff BA, Greer BE, Paley PJ. Gray HJ, et al. Gynecol Oncol. 2002 May;85(2):274-7. doi: 10.1006/gyno.2001.6523. Gynecol Oncol. 2002. PMID: 11972387

3

Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma.

Garg R, Wollan M, Galic V, Garcia R, Goff BA, Gray HJ, Swisher E. Garg R, et al. Among authors: gray hj. Gynecol Oncol. 2006 Dec;103(3):793-6. doi: 10.1016/j.ygyno.2006.08.043. Epub 2006 Oct 4. Gynecol Oncol. 2006. PMID: 17023036 Free PMC article.

4

An evaluation of cervical cancer in women age sixty and over.

Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, Goff BA. Fox KV, et al. Among authors: gray hj. Gynecol Oncol. 2008 Apr;109(1):53-8. doi: 10.1016/j.ygyno.2007.12.028. Epub 2008 Feb 5. Gynecol Oncol. 2008. PMID: 18255127

5

Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.

Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Shah CA, et al. Among authors: gray hj. Gynecol Oncol. 2008 May;109(2):215-9. doi: 10.1016/j.ygyno.2008.01.010. Epub 2008 Mar 7. Gynecol Oncol. 2008. PMID: 18314181

6

Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.

Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Gray HJ, et al. Gynecol Oncol. 2010 Mar;116(3):340-4. doi: 10.1016/j.ygyno.2009.10.054. Epub 2009 Nov 17. Gynecol Oncol. 2010. PMID: 19922987

7

Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction.

McLean KA, Shah CA, Thompson SA, Gray HJ, Swensen RE, Goff BA. McLean KA, et al. Among authors: gray hj. Gynecol Oncol. 2010 Jul;118(1):43-6. doi: 10.1016/j.ygyno.2010.03.002. Epub 2010 Apr 27. Gynecol Oncol. 2010. PMID: 20398918

8

FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.

Press JZ, Allison KH, Garcia R, Everett EN, Pizer E, Swensen RE, Tamimi HK, Gray HJ, Peters WA 3rd, Goff BA. Press JZ, et al. Among authors: gray hj. Gynecol Oncol. 2011 Feb;120(2):296-9. doi: 10.1016/j.ygyno.2010.10.019. Gynecol Oncol. 2011. PMID: 21075432

9

Pelvic exenteration in the age of modern chemoradiation.

McLean KA, Zhang W, Dunsmoor-Su RF, Shah CA, Gray HJ, Swensen RE, Goff BA. McLean KA, et al. Among authors: gray hj. Gynecol Oncol. 2011 Apr;121(1):131-4. doi: 10.1016/j.ygyno.2010.11.044. Epub 2011 Jan 21. Gynecol Oncol. 2011. PMID: 21256580

10

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.

Thrall MM, Gray HJ, Symons RG, Weiss NS, Flum DR, Goff BA. Thrall MM, et al. Among authors: gray hj. Gynecol Oncol. 2011 Jul;122(1):100-6. doi: 10.1016/j.ygyno.2011.03.022. Epub 2011 Apr 15. Gynecol Oncol. 2011. PMID: 21496889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters